Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bioanalytical testing services market will help companies and investors design strategic landscapes.
Increased R&D investment is expected to drive Norway's bioanalytical testing services market. As new drugs or formulations are developed, there will be a greater need for bioanalytical testing to assess these new products' pharmacokinetics, bioavailability, and safety.
This can drive the demand for bioanalytical testing services from specialized laboratories. For instance, In April 2023, Next Pharma acquired Takeda's primary European chewable tablet manufacturing facility in Asker, Norway.
By acquiring a manufacturing site, Next Pharma will likely increase its production capacity for chewable tablets. This expansion in manufacturing output could lead to a higher demand for bioanalytical testing services to ensure the quality & compliance of the produced pharmaceuticals.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway bioanalytical testing services market , including forecasts for subscribers. This country databook contains high-level insights into Norway bioanalytical testing services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account